Meet our Scientific Advisory Committee
We receive around 500 ideas from scientists all over the world every year and we want to make sure only the most innovative, creative and exciting research is funded. That’s where our external team of cancer experts, also known as our Scientific Advisory Committee, come in.
How do we ensure we use your donations to fund the best research?
Made up of eminent cancer specialists who volunteer their time to assess, review, and judge the ideas we receive each year, our Committee select projects based on the quality of the science and the novelty of the idea.
The breadth of knowledge and depth of experience of our members ensures we only fund research of the highest calibre.
The members of our Scientific Advisory Committee all have different areas of expertise across a range of different cancer types, branches of biology, chemistry, medicine, and drug development.
These differences in perspective are crucial when it comes to deciding the best projects to support. Since we fund research involving lots of different scientific techniques and all cancer types, we need a broad and varied committee to help spot the ideas with the best chance of having real impact.
We are proud to have our Committee's expertise on board to help us evaluate and select the projects we fund with our Curestarters' generous donations.
As a former grant holder I am aware of what a difference a Worldwide Cancer Research award can make. Now, as the Chair of the Scientific Advisory Committee it is a privilege to explore the incredible research ideas submitted from across the world by applicants and work with an international group of experts to fund the most exciting ideas to help understand, treat and prevent cancer.
Meet our members:
Professor Simon Leedham
University of Oxford, United Kingdom
Dr George Zachos
University of Crete, Greece
Professor Amy Berrington
The Institute of Cancer Research, United Kingdom
Dr Aura Carreira
Centro de Biologia Molecular Severo Ochoa (CBM) CSIC-UAM, Madrid, Spain
Professor Joao Matos
Max Perutz Labs, Austria
Dr Pim French
Erasmus University Medical Center, Netherlands
Dr Vincenzo Giambra
Fondazione IRCCS Casa Sollievo della Sofferenza, Italy
Dr Denes Hnisz
Max Planck Institute of Molecular Genetics, Germany
Dr Daniel Hodson
University of Cambridge, United Kingdom
Professor Musa Mhlanga
Radboud University, The Netherlands
Dr Sheeba Irshad
King's College London, United Kingdom
Dr Helder Maiato
i3S - Instituto de Investigação e Inovação em Saúde, Portugal
Dr Miriam Martini
University of Turin, Italy
Professor Ruth Palmer
University of Gothenburg, Sweden
Professor Krishnaraj Rajalingam
University of Mainz, Germany
Dr Laura Rosenberg
Astra Zeneca United Kingdom
Dr Sharon Rossiter
University of Hertfordshire, United Kingdom
Professor Pipsa Saharinen
University of Helsinki, Finland
Position to be filled
Dr Sara Sigismund
University of Milan, Italy
Professor Bruno Silva-Santos
University of Lisbon, Portugal
Professor Louis Vermeulen
Genetech, USA and Academic Medical Center, Netherlands
Dr Danijela Vignjevic
Institut Curie, France
Professor David Withers
University of Birmingham, United Kingdom
